Treatment of coronary bifurcation lesions with drug-eluting stents: insights from the first phase of the prospective multicenter german drug-eluting stent registry.
暂无分享,去创建一个
S. Silber | K. Kuck | C. Nienaber | M. Hochadel | J. Senges | I. Akin | U. Tebbe | G. Richardt | G. Sabin | M. Ferenc | M. Abdel-Wahab | A. Mostafa | M. Abdel‐Wahab | Miroslaw Ferenc
[1] M. Jeong,et al. Sirolimus- versus paclitaxel-eluting stents for the treatment of coronary bifurcations results: from the COBIS (Coronary Bifurcation Stenting) Registry. , 2010, Journal of the American College of Cardiology.
[2] A. Baumbach,et al. Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions: The British Bifurcation Coronary Study: Old, New, and Evolving Strategies , 2010, Circulation.
[3] S. Willich,et al. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry). , 2009, The American journal of cardiology.
[4] Dick M. Goedhart,et al. Three-year clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularisation Therapies Study, part II (ARTS II). , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[5] Antonio Colombo,et al. Bifurcation disease: what do we know, what should we do? , 2008, JACC. Cardiovascular interventions.
[6] P. Serruys,et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions , 2007, Circulation.
[7] Antonio Colombo,et al. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II). , 2007, European heart journal.
[8] H. Bøtker,et al. Comparison of sirolimus-eluting and bare metal stents in coronary bifurcation lesions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease Trial (SCANDSTENT). , 2006, American heart journal.
[9] M. Niemelä,et al. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions: The Nordic Bifurcation Study , 2006, Circulation.
[10] P. Serruys,et al. Long-term outcomes after stenting of bifurcation lesions with the "crush" technique: predictors of an adverse outcome. , 2006, Journal of the American College of Cardiology.
[11] B. Gersh. Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .
[12] I. Iakovou,et al. In-hospital and nine-month outcome of treatment of coronary bifurcational lesions with sirolimus-eluting stent. , 2005, The American journal of cardiology.
[13] P. Serruys,et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. , 2005, Journal of the American College of Cardiology.
[14] K. Detre,et al. Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.
[15] E. Vañó,et al. Clinical and technical determinants of the complexity of percutaneous transluminal coronary angioplasty procedures: Analysis in relation to radiation exposure parameters , 2000, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[16] C. Di Mario,et al. Immediate and long-term results of "T" stenting for bifurcation coronary lesions. , 2000, The American journal of cardiology.
[17] J. Tobis,et al. Bifurcation lesions: two stents versus one stent--immediate and follow-up results. , 2000, Journal of the American College of Cardiology.
[18] H. Hecht,et al. Lesion morphology and coronary angioplasty: current experience and analysis. , 1992, Journal of the American College of Cardiology.